Logo image of GLAQ

GLOBIS ACQUISITION CORP (GLAQ) Stock Fundamental Analysis

NASDAQ:GLAQ - Nasdaq - US3795821095 - Common Stock

9.47  -0.59 (-5.87%)

After market: 9.45 -0.02 (-0.21%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GLAQ. GLAQ was compared to 0 industry peers in the Unkown industry. GLAQ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GLAQ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GLAQ had negative earnings in the past year.
GLAQ Yearly Net Income VS EBIT VS OCF VS FCFGLAQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

Industry RankSector Rank
ROA -2.84%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GLAQ Yearly ROA, ROE, ROICGLAQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 -0.5 -1 -1.5 -2

1.3 Margins

GLAQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLAQ Yearly Profit, Operating, Gross MarginsGLAQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for GLAQ has been reduced compared to 1 year ago.
GLAQ has a worse debt/assets ratio than last year.
GLAQ Yearly Shares OutstandingGLAQ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 5M 10M 15M
GLAQ Yearly Total Debt VS Total AssetsGLAQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

GLAQ has an Altman-Z score of 14.76. This indicates that GLAQ is financially healthy and has little risk of bankruptcy at the moment.
GLAQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.76
ROIC/WACCN/A
WACCN/A
GLAQ Yearly LT Debt VS Equity VS FCFGLAQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.01 indicates that GLAQ may have some problems paying its short term obligations.
A Quick Ratio of 0.01 indicates that GLAQ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
GLAQ Yearly Current Assets VS Current LiabilitesGLAQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

GLAQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2866.67%.
EPS 1Y (TTM)-2866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-194.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLAQ Yearly Revenue VS EstimatesGLAQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021
GLAQ Yearly EPS VS EstimatesGLAQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GLAQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GLAQ Price Earnings VS Forward Price EarningsGLAQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GLAQ Per share dataGLAQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GLAQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLOBIS ACQUISITION CORP

NASDAQ:GLAQ (6/9/2022, 8:18:41 PM)

After market: 9.45 -0.02 (-0.21%)

9.47

-0.59 (-5.87%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.45%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap142.52M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.5
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.84%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 14.76
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-194.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A